← Open Payments lookup

CAROLINE LEITHNER: Open Payments

NPI 1609312008 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,264 in 70 payments from 10 companies in 2025. Trend: 2023 $2,205 · 2024 $2,273 · 2025 $1,264

Food & beverage: $1,264
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.27$322
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$277
E.R. Squibb & Sons, L.L.C.8$251
Otsuka America Pharmaceutical, Inc.6$110
Janssen Pharmaceuticals, Inc5$86
ABBVIE INC.3$78
Alkermes, Inc.3$47
Axsome Therapeutics, Inc.2$44
Teva Pharmaceuticals USA, Inc.2$35
Supernus Pharmaceuticals, Inc.1$14

Products named: INGREZZA, CAPLYTA, COBENFY, VRAYLAR, INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA, ARISTADA.

Industry payments across OK — which companies pay providers there.